Gene · 710
NIH grants1,786
NIH grants whose papers are about the gene, through NIH's grant-paper links.
761 to 780 of 1,786
Download this page as JSON| Grant | Title | SERPING1 papers | Newest fiscal year |
|---|---|---|---|
| R01AG054076 | Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham Cohorts | 1 | 2020 |
| R01AI020624 | Analysis of Staphylococcus Aureus Host Interactions. | 1 | 2020 |
| R01AI085090 | Mechanisms of Disease Pathogenesis in Regulatory T cell Deficiency | 1 | 2020 |
| R01AI091707 | Type I interferon-stimulated genes and the antiviral immune response | 1 | 2020 |
| R01AI100887 | Immune repertoire and function in typical and atypical SCID | 1 | 2020 |
| R01AI122369 | Hepatocyte xenografts for treatment of acute liver failure | 1 | 2020 |
| R01AI126909 | Pathogenesis of HRPII in Cerebral Malaria | 1 | 2020 |
| R01AI130684 | Exploring the biology ofÃÂ O-acetylÃÂ sialic acids using stable syntheticÃÂ mimics | 1 | 2020 |
| R01CA136494 | Molecular Mechanism of Antiangiogenic Properties of Gold Nanoparticle | 1 | 2020 |
| R01CA208205 | Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment | 1 | 2020 |
| R01DE024153 | Neutrophil homeostasis and periodontitis: Novel concepts and treatments | 1 | 2020 |
| R01DK113790 | Purinergic signaling in granuloma-forming Th2 immunity | 1 | 2020 |
| R01EY013434 | Approaches to enhance lysosomal function in RPE cells | 1 | 2020 |
| R01EY025779 | Enhancing photoreceptor integration using microglia-derived secreted factors | 1 | 2020 |
| R01GM066189 | Purinergic signaling in trauma and sepsis | 1 | 2020 |
| R01GM112639 | Inhibitor Reprogramming of a Human Histone Deacetylase Protein Interaction Network | 1 | 2020 |
| R01HG009141 | A powerful web-based discovery platform for rare disease genetics | 1 | 2020 |
| R01HL107386 | Platelet and megakaryocyte biology in the normal and injured lung | 1 | 2020 |
| R01HL115334 | Understanding the unique role endogenous APC subtypes play during the rejection of MAg-mismatched cells | 1 | 2020 |
| R01HL130423 | Toward Therapeutic Manipulation of Endothelial to Mesenchymal Transition | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/grants?page=39